Total amount raised
$171 Millions
Latest funding date
09/01/2022
Location
Ceribell has developed a range of EEG technology products aimed at improving the detection and treatment of seizures, particularly in critically ill patients. The company's offerings include a portable EEG system for rapid assessment and an online platform for accessing EEG data.
Keep reading to explore the intricacies of Ceribell's fundraising journey and the investors backing this innovative platform.
What Is Ceribell?
Founded in Sunnyvale, CA, Ceribell is dedicated to enhancing patient care through innovative EEG technology. The company specializes in Point-of-Care EEG systems that facilitate rapid and accurate seizure detection in critical care settings.
While the exact founding year and the names of the founders are not available, Ceribell's headquarters are located at 360 N Pastoria Avenue, Sunnyvale, CA 94085. The company focuses on providing solutions for intensive care units, emergency departments, and neurology departments.
Unfortunately, the number of employees at Ceribell is not specified. However, the company's commitment to improving seizure detection and treatment remains evident through its advanced medical technology offerings.
How Much Funding Has Ceribell Raised?
- Series A
- Amount Raised: $13M
- Date: May 2017
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and launch their initial EEG technology.
- Series B
- Amount Raised: $35M
- Date: September 2018
- Lead Investors: Optimas Capital Partners Fund, The Rise Fund
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the product line and enhance the technology.
- Debt Financing
- Amount Raised: $20M
- Date: May 2020
- Lead Investors: Horizon Technology Finance
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing operations and product development.
- Series C
- Amount Raised: $53M
- Date: April 2021
- Lead Investors: Longitude Capital, The Rise Fund
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale commercial operations and enhance machine learning capabilities.
- Series C Extension
- Amount Raised: $50M
- Date: September 2022
- Lead Investors: Ally Bridge Group
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support commercial expansion and improve EEG accessibility for other neurological conditions.
Total Amount Raised: $171M. Current Valuation: Not publicly disclosed.
Key Investors
The major investors in Ceribell are as follows:
- Ally Bridge Group
- Details: Ally Bridge Group is a global healthcare-focused investment group that invests in both private and public companies. They led Ceribell's $50 million funding round.
- Investment Focus Areas: Healthcare, medical technologies, life sciences
- Notable Investments: Not publicly disclosed
- Longitude Capital
- Details: Longitude Capital is a venture capital firm that invests in transformative healthcare companies. They participated in Ceribell's $53 million Series C round.
- Investment Focus Areas: Biotechnology, medical devices, healthcare services
- Notable Investments: Axonics Modulation Technologies, Inozyme Pharma, Rapid Micro Biosystems
- The Rise Fund
- Details: The Rise Fund is a global impact investment fund managed by TPG, focusing on achieving social and environmental impact alongside competitive financial returns. They have invested in multiple rounds for Ceribell.
- Investment Focus Areas: Education, healthcare, financial services
- Notable Investments: EverFi, DreamBox Learning, Dodla Dairy
- Optimas Capital Partners Fund
- Details: Optimas Capital Partners Fund is a private equity firm that focuses on growth-stage investments. They were a key investor in Ceribell's $35 million Series B round.
- Investment Focus Areas: Technology, healthcare, consumer products
- Notable Investments: Not publicly disclosed
- Horizon Technology Finance
- Details: Horizon Technology Finance is a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies. They provided $20 million in debt financing to Ceribell.
- Investment Focus Areas: Technology, life sciences, healthcare information and services
- Notable Investments: Not publicly disclosed
What's Next for Ceribell?
With the recent $50 million funding, Ceribell is poised to expand its rapid response EEG system into more emergency departments and intensive care units. This opportunity is significant, as it aims to enhance the efficiency of diagnosing neurological conditions, leveraging machine learning to broaden the scope beyond seizures.
Future fundraising seems likely, given the ongoing commercial expansion and the potential for new diagnostic solutions. However, Ceribell may face challenges such as competition from other companies in the seizure-detection space and regulatory hurdles for new applications of their technology.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Ceribell and gather other critical business insights.
Sign up for free and start exploring the wealth of information available at Clay.
